Filing Details
CAPRICOR THERAPEUTICS, INC. (NASDAQ:CAPR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 10, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:CAPR
CAPRICOR THERAPEUTICS, INC. (CAPR) Files Quarterly Report for Q0
CAPRICOR THERAPEUTICS, INC. (NASDAQ:CAPR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 10, 2026.
At publication ·
What changed
CAPRICOR THERAPEUTICS, INC. (NASDAQ:CAPR) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Capricor Therapeutics filed its quarterly 10-Q report with the SEC on November 10, 2026.
- The company's stock trades at $8.87 per share with a market capitalization of $1.2 billion.
- The 10-Q filing includes unaudited financial statements and management commentary on business performance and emerging trends.
Market Context
CAPRICOR THERAPEUTICS, INC.'s stock currently trades at $8.87 with a market capitalization of $1.2B.
The 10-Q provides CAPRICOR THERAPEUTICS, INC.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for CAPRICOR THERAPEUTICS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CAPR Stock Page
Frequently Asked Questions
Where can I read CAPR's SEC filings?
Browse all filings on our CAPR SEC filings page.
What types of SEC filings does CAPRICOR THERAPEUTICS, INC. file?
Public companies like CAPRICOR THERAPEUTICS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
